ArticleInfection and drug resistance2019

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study.

Arturo Ortiz-Álvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.